XLO NASDAQ
Xilio Therapeutics, Inc.
1W: -0.3%
1M: +1.9%
3M: -4.6%
YTD: +1241.4%
1Y: +982.1%
3Y: +327.0%
$9.01
+0.10 (+1.12%)
Weekly Expected Move ±2.0%
$9
$9
$9
$9
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
ESG Scores — XLO
Company vs Sector Average
Historical ESG Trend
View All ESG Filings (17)
| Date | Form | Environmental | Social | Governance | ESG Score | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | 10-Q | 53.2 | 62.6 | 60.8 | 58.8 | SEC ↗ |
| 2026-03-31 | 10-Q | 53.2 | 62.6 | 60.4 | 58.7 | SEC ↗ |
| 2025-12-31 | 10-K | 54.9 | 64.2 | 63.1 | 60.7 | SEC ↗ |
| 2025-09-30 | 10-Q | 53.9 | 61.7 | 59.2 | 58.2 | SEC ↗ |
| 2025-03-31 | 10-Q | 55.3 | 63.4 | 59.7 | 59.5 | SEC ↗ |
| 2024-12-31 | 10-K | 52.2 | 63.8 | 61.9 | 59.3 | SEC ↗ |
| 2024-09-30 | 10-Q | 55.3 | 61.4 | 59.0 | 58.5 | SEC ↗ |
| 2024-06-30 | 10-Q | 56.5 | 61.3 | 58.4 | 58.7 | SEC ↗ |
| 2024-03-31 | 10-Q | 56.4 | 61.7 | 59.1 | 59.0 | SEC ↗ |
| 2023-12-31 | 10-K | 52.2 | 63.9 | 61.0 | 59.0 | SEC ↗ |
| 2023-09-30 | 10-Q | 55.5 | 63.0 | 58.9 | 59.1 | SEC ↗ |
| 2023-06-30 | 10-Q | 55.3 | 62.2 | 59.4 | 59.0 | SEC ↗ |
| 2023-03-31 | 10-Q | 55.8 | 61.7 | 59.6 | 59.0 | SEC ↗ |
| 2022-12-31 | 10-K | 50.2 | 63.2 | 62.9 | 58.8 | SEC ↗ |
| 2022-09-30 | 10-Q | 57.9 | 61.9 | 60.6 | 60.1 | SEC ↗ |
| 2022-06-30 | 10-Q | 56.6 | 62.0 | 60.6 | 59.7 | SEC ↗ |
| 2021-12-31 | 10-K | 53.5 | 63.9 | 64.0 | 60.5 | SEC ↗ |